Novo Nordisk to cut 9,000 jobs |
Novo Nordisk, the maker of weight-loss drug Wegovy, is to cut 9,000 jobs, or about 11.5% of its workforce, in a restructuring that aims to save 8bn Danish crowns ($1.26bn) annually. "Novo Nordisk today announced a company-wide transformation to simplify its organization, improve the speed of decision-making, and reallocate resources towards the company's growth opportunities in diabetes and obesity," the company said. Novo, which has 78,400 roles globally, said about 5,000 of the job cuts will be in its native Denmark. |
|